| Autor: |
da Silva TPF; Hospital Vila Nova Star, Rede D'Or, São Paulo, SP, Brazil., Moreno RA; Hospital Vila Nova Star, Rede D'Or, São Paulo, SP, Brazil., Polizio RP; Hospital Vila Nova Star, Rede D'Or, São Paulo, SP, Brazil., de Melo RAB; Hospital Vila Nova Star, Rede D'Or, São Paulo, SP, Brazil., Macedo ALV; Hospital Vila Nova Star, Rede D'Or, São Paulo, SP, Brazil., de Brito LTS; Hospital Vila Nova Star, Rede D'Or, São Paulo, SP, Brazil. |
| Abstrakt: |
Pancreatic ductal adenocarcinoma is one of the most aggressive malignant neoplasms, with a one-year survival rate below 20%. Axial methods (computed tomography and magnetic resonance imaging) play a fundamental role in the diagnosis and staging of the disease, because they provide adequate anatomical resolution in the assessment of key structures, mainly vascular structures. Pancreatic ductal adenocarcinoma is most often discovered in advanced stages, when surgical resection is no longer feasible. In that scenario, minimally invasive treatment alternatives have been developed in attempts to change the natural history of the disease. Irreversible electroporation, an interventional procedure that minimizes deleterious effects on adjacent tissues, has proven useful for the treatment of tumors traditionally considered unresectable. Despite the growing acknowledgment of this technique as a tool for the management of pancreatic ductal adenocarcinoma, it is still relatively unknown among radiologists. In this study, we sought to provide an overview of the main characteristics and eligibility criteria that must be considered for the indication of irreversible electroporation in cases of pancreatic ductal adenocarcinoma. |
